Location History:
- Jiangsu, CN (2019 - 2021)
- Suzhou, CN (2020 - 2022)
Company Filing History:
4 out of 20 
2 out of 55 Years Active: 2019-2022
Title: **Cheng Chen: A Leading Innovator in Antibody Research**
Introduction
Cheng Chen, an accomplished inventor based in Jiangsu, China, has made significant contributions to the field of biotechnology, specifically in the development of therapeutic antibodies. With a total of six patents under his name, his work addresses critical challenges in cancer treatment and diagnosis, showcasing his expertise and innovative capabilities.
Latest Patents
Among Cheng Chen's notable patents is the "Anti-OX40 antibody and use thereof". This invention focuses on an antibody and its fragments that effectively bind to OX40, offering potential for various therapeutic applications. The invention also includes a nucleic acid encoding the antibody and host cells that express it, emphasizing its versatile use in treatment and diagnostics.
Additionally, his patent for "PD-1 antibodies" discusses antibodies that target the human programmed cell death 1 (PD-1) pathway. These antibodies are significant for cancer therapy, potentially enhancing treatment efficacy when used alone or in combination with chemotherapy and other cancer treatments.
Career Highlights
Cheng Chen has had an impressive career, significantly shaping the landscape of antibody research. He has worked with Innovent Biologics (Suzhou) Co., Ltd., a prominent biopharmaceutical company that focuses on developing and commercializing innovative medicines, particularly in oncology. Furthermore, he has been associated with Jiangsu University of Science and Technology, reinforcing his academic and professional contributions to the field.
Collaborations
Throughout his career, Cheng has collaborated with esteemed colleagues such as Xiaolin Liu and Andy Tsun, furthering advancements in antibody technology. These collaborations have played a crucial role in enhancing the scope and impact of his innovations in therapeutic applications.
Conclusion
Cheng Chen stands out as a key figure in the realm of antibody research, with a profound impact illustrated through his patents and collaborations. His innovative approach is paving the way for new treatments in cancer therapy, showcasing the vital role of inventors in enhancing healthcare and medical science.